Sotera Health (NYSE:SHC – Get Rating) is scheduled to be announcing its earnings results before the market opens on Thursday, August 4th. Analysts expect the company to announce earnings of $0.23 per share for the quarter. Sotera Health has set its FY22 guidance at $0.93-0.99 EPS.Investors interested in registering for the company’s conference call can do so using this link.
Sotera Health (NYSE:SHC – Get Rating) last announced its earnings results on Thursday, May 5th. The company reported $0.20 earnings per share for the quarter, beating the consensus estimate of $0.18 by $0.02. Sotera Health had a net margin of 14.30% and a return on equity of 42.65%. The company had revenue of $237.00 million during the quarter, compared to the consensus estimate of $229.40 million. During the same period last year, the firm earned $0.13 earnings per share. Sotera Health’s revenue was up 11.8% compared to the same quarter last year. On average, analysts expect Sotera Health to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.
Sotera Health Trading Up 1.2 %
NYSE:SHC opened at $18.95 on Thursday. Sotera Health has a 12 month low of $17.73 and a 12 month high of $27.38. The firm has a fifty day simple moving average of $20.19 and a 200-day simple moving average of $20.76. The company has a current ratio of 2.58, a quick ratio of 2.27 and a debt-to-equity ratio of 2.78. The company has a market capitalization of $5.36 billion, a P/E ratio of 38.67 and a beta of 0.43.
Institutional Inflows and Outflows
Analyst Upgrades and Downgrades
Several research firms have recently commented on SHC. Wolfe Research downgraded shares of Sotera Health from an “outperform” rating to a “peer perform” rating and set a $26.00 price objective for the company. in a research note on Thursday, June 9th. Barclays lowered their price objective on shares of Sotera Health from $24.00 to $22.00 and set an “equal weight” rating for the company in a research note on Wednesday, July 13th. Three investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $25.83.
About Sotera Health
Sotera Health Company provides sterilization, and lab testing and advisory services in the United States, Canada, Europe, and internationally. The company's sterilization services include gamma and electron beam irradiation, and EO processing; Nelson Labs comprise microbiological and analytical chemistry testing; and advisory services for medical device and biopharmaceutical industries.
- Get a free copy of the StockNews.com research report on Sotera Health (SHC)
- The MarketBeat Podcast: Portfolio Management in Market Downturns
- Can These Two Airline Stocks Overcome Gravity And Fly Higher?
- Shopify Stock Rallies Despite Quarterly Loss
- Two Automation Stocks The Institutions Are Buying
- Can Owens-Corning Insulate Your Portfolio?
Receive News & Ratings for Sotera Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sotera Health and related companies with MarketBeat.com's FREE daily email newsletter.